期刊文献+

维吾尔族AECOPD住院患者用药分析及药学监护思考

Analysis of drug use and pharmaceutical care ideas in uygur AECOPD inpatients
下载PDF
导出
摘要 目的探讨临床药师对维吾尔族AECOPD患者提供药学监护的必要性。方法临床药师采集临床数据,分析喀什地区111名维吾尔族AECOPD住院患者抗菌药物应用指征和长效吸入剂使用情况。结果91例(82%)患者使用抗菌药物,其中降钙素原<0.1 ng/ml的86人中有66人使用抗菌药物(76.74%);53例(47.7%)未长期使用吸入剂。结论少数患者无指征使用抗菌药物;临床药师需要通过了解患者症状、体征、实验室检查判断使用抗菌药物指征;药师需要通过AECOPD患者教育、评估病情、会诊、管理、随访,有重点地做好分层药学监护。 Objective To explore the necessity of providing pharmaceutical care for uygur AECOPD patients by clinical pharmacists.Methods Clinical pharmacists collected clinical data.Clinical pharmacists analyzed the application indications of antibiotics in 111 uygur AECOPD inpatients in kashgar,and the use of long-acting inhalants.Results Of the 111 patients,91 cases(82%)were treated with antibiotics.Of the 86 patients with procalcitonin<0.1 ng/ml,66 cases(76.74%)were treated with antibiotics.Of the 111 patients,53 cases(47.7%)did not use inhalants for long periods.Conclusions A small number of patients were given antibiotics without indications.Clinical pharmacists need to know the symptoms,signs,and laboratory tests of the patients to judge the indications of antibioticsusage.Pharmacists need to conduct stratified pharmaceutical care through providing medication education to AECOPD patients,assessment,consultation,management,and follow-up.
作者 高亚敏 赵波 徐鹏丽 邹小广 Gao Yamin;Zhao Bo;Xu Pengli;Zou Xiaoguang(Department of Pharmacy,The First People's Hospital of Kashgar,Kashgar 844000,China)
出处 《国际医药卫生导报》 2019年第24期4000-4002,共3页 International Medicine and Health Guidance News
基金 喀什地区科学研究与技术开发计划项目(KS2017031)。
关键词 维吾尔族 AECOPD 药学监护 The uighurs AECOPD Pharmaceutical care
  • 相关文献

参考文献7

二级参考文献45

  • 1黄俊芳,王广发.慢性阻塞性肺病全球倡议慢性阻塞性肺病指南(2013更新版)解读[J].中国医学前沿杂志(电子版),2013,5(3):58-60. 被引量:60
  • 2金哲,王广发.慢性阻塞性肺疾病全球倡议(2014更新版)解读[J].中国医学前沿杂志(电子版),2014,6(2):94-97. 被引量:142
  • 3刘笑然,丁春华,朱宝玉.慢性阻塞性肺疾病的氧化应激[J].国外医学(呼吸系统分册),2005,25(6):414-416. 被引量:9
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1795
  • 5Bestall JC,Paul EA,Garrod R,et al.Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease[J].Thorax,1999,54:581-586.
  • 6Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in china:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176:753-760.
  • 7Regional COPD Working Group.COPD prevalence in 12 Asia Pacific Countriesand regions:projections based on the COPD prevalence estimation model[J].Respiration,2003,8:192-198.
  • 8van Schayck CP,Loozen JMC.Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice:cross sectional case finding study[J].Br Med J,2002,324:1370.
  • 9Huttner H,Beyer M,Bargon J,et al.Charcoal smoke causes bronchial anthracosis and COPD[J].Med Clin,2007,102(1):59-63.
  • 10Bailis R,Ezzati M,Kammen DM.Mortality and greenhouse gas impacts of biomass and petroleum energy futures in Africa[J].Science,2005,308:98-103.

共引文献1610

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部